NASDAQ: RDHL - RedHill Biopharma Ltd.

Rentabilidade por seis meses: -23.65%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção RedHill Biopharma Ltd.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa RedHill Biopharma Ltd.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults.

mais detalhes
Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2013-01-07
ISIN US7574681034
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.redhillbio.com
Цена ао 0.4797
Alteração de preço por dia: +5.5% (6.55)
Alteração de preço por semana: +6.31% (6.5)
Alteração de preço por mês: -13.19% (7.96)
Alteração de preço em 3 meses: -19.93% (8.63)
Mudança de preço em seis meses: -23.65% (9.05)
Mudança de preço por ano: +370.07% (1.47)
Mudança de preço em 3 anos: +161.74% (2.64)
Mudança de preço em 5 anos: +11.27% (6.21)
Mudança de preço em 10 anos: 0% (6.91)
Mudança de preço desde o início do ano: -12.64% (7.91)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 36.55 1
P/BV 115.06 1
P/E 9.95 9
EV/EBITDA -7.93 0
Total: 5.38

Eficiência

Nome Significado Nota
ROA, % 103.77 10
ROE, % 1155.91 10
Total: 5

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0399 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 3.38 1
Rentabilidade Ebitda, % -164.64 0
Rentabilidade EPS, % -106.74 0
Total: 0.2
Mais detalhes

Instituições Volume Compartilhar, %
Gagnon Securities, LLC 89589 10.16
JANE STREET GROUP, LLC 86812 9.85
Rhumbline Advisers 34847 3.95
We Are One Seven, LLC 15750 1.79
Squarepoint Ops LLC 10947 1.24
Group One Trading, L.P. 615 0.07
Morgan Stanley 576 0.07
Aspire Private Capital, LLC 405 0.05
Royal Bank of Canada 142 0.02
Steward Partners Investment Advisory, LLC 125 0.01



Supervisor Cargo Pagamento Ano de nascimento
Mr. Dror Ben-Asher Co-Founder, Chairman & CEO 594.61k 1966 (59 anos)
Mr. Gilead Raday MPhil, MSc Chief Operating Officer 365.56k 1975 (50 anos)
Mr. Adi Frish Chief Corporate & Business Development Officer 339.3k 1970 (55 anos)
Mr. Rick D. Scruggs Chief Commercial Officer, President of RedHill Biopharma Inc. & Director 469.8k 1960 (65 anos)
Mr. Razi Ingber Chief Financial Officer 339.82k 1984 (41 ano)
Ms. Alexandra Okmian Senior Business Development & Investor Relations Manager N/A
Dr. Reza Fathi Ph.D. Senior Vice President of Research & Development 299.29k 1955 (70 anos)
Ms. Patricia Anderson B.Sc. RAC Senior Vice President of Regulatory Affairs N/A
Mr. Guy Goldberg J.D. Chief Business Officer 338.13k 1976 (49 anos)

Endereço: Israel, Tel Aviv, 21 Ha’arba’a Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.redhillbio.com